WELCOMING SESSION
LASEINE
Jean-Philippe SPANO
Jean-Philippe SPANO
CONSENSUS AND GUIDELINES FOR LUNG CANCER (1)
LASEINE
Under the auspices of our respective groups: IFCT, Oncology Group SPLF
Presidents: Virginie Westeel, Frances Shepherd - Chairpersons: Alessio Mariolo, Sébastien Thureau, Marie Wislez
Infralobar resections.
Infralobar resections.
Alessio Mariolo
Alessio Mariolo
Update on perioperative immunotherapy.
Update on perioperative immunotherapy.
Marie Wislez
Marie Wislez
Update on Post-operative Treatment of Resected EGFR NSCLC.
Update on Post-operative Treatment of Resected EGFR NSCLC.
Frances Shepherd
Frances Shepherd
Ongoing studies of radiotherapy and perspectives.
Ongoing studies of radiotherapy and perspectives.
Etienne Martin
Etienne Martin
CONSENSUS AND GUIDELINES FOR LUNG CANCER (2)
LASEINE
Under the auspices of our respective groups: IFCT, Oncology Group SPLF
Presidents: Elisabeth Quoix, Frances Shepherd - Chairpersons: Françoise Mornex, Diane Damotte
Oligometastatic disease: concept, therapeutic challenges and strategies.
Oligometastatic disease: concept, therapeutic challenges and strategies.
Ania Wrona, Françoise Mornex
Ania Wrona, Françoise Mornex
When should immunotherapy be stopped in responders?
When should immunotherapy be stopped in responders?
Céline Mascaux
Céline Mascaux
Malignant pleural mesothelioma.
Malignant pleural mesothelioma.
Arnaud Scherpereel
Arnaud Scherpereel
Olivier Tredant
Olivier Tredant
PRECISION MEDICINE IN GYNECOLOGIC AND PROSTATE CANCER
MISSISSIPI
PARP inhibtors in prostate cancer.
PARP inhibtors in prostate cancer.
Pierre Mongiat-Artus
Pierre Mongiat-Artus
Immunotherapy in gynecologic cancer : state of the art.
Immunotherapy in gynecologic cancer : state of the art.
Alexandra Leary
Alexandra Leary
European consensus on HRD in ovarian cancer.
European consensus on HRD in ovarian cancer.
Diether Lambrechts
Diether Lambrechts
Development of HRD solutions.
Development of HRD solutions.
Pascal Pujol
Pascal Pujol
Opening Session: THE FUTURE OF ONCOLOGY (Basic Science)
MISSISSIPI
Presidents and Chairpersons: Manuel Rodrigues, Jacques-Olivier Bay, Jean-Pierre Armand and Jacques Robert
Introduction:
Introduction:
Jean-Philippe Spano, Jacques Robert
Jean-Philippe Spano, Jacques Robert
Management of breast cancer from Halsted to personalised medicine: what to expect tomorrow?
Management of breast cancer from Halsted to personalised medicine: what to expect tomorrow?
Jean-Yves Pierga, (Medical oncologist, Institut Curie, Paris)
Jean-Yves Pierga, (Medical oncologist, Institut Curie, Paris)
Supportive care in 2030.
Supportive care in 2030.
Carole Bouleuc, (Head of the Support CareDepartment, Institut Curie, Paris)
Carole Bouleuc, (Head of the Support CareDepartment, Institut Cur...
Radiotherapy in 2030.
Radiotherapy in 2030.
Laurent Quero, (Oncologist Radiotherapist, Hôpital St Louis, Paris)
Laurent Quero, (Oncologist Radiotherapist, Hôpital St Louis, Pari...
Tomorrow, the advent of preventive precision medicine.
Tomorrow, the advent of preventive precision medicine.
Pierre Saintigny, (Medical oncologist at the Léon Bérard Centre and Team Leader at the Lyon Cancer Research Centre)
Pierre Saintigny, (Medical oncologist at the Léon Bérard Centre a...
SESSION GEMO "GROUPE EUROPÉEN D'ETUDE DES MÉTASTASES OSSEUSES"
STLAURENT
Sous l'égide du groupe GEMO
Presidents and Chairpersons: Marie-Hélène Vieillard, Frédéric Clarençon and Laetitia Morardet
How to limit bone complications in patients with prostate and breast cancer.
How to limit bone complications in patients with prostate and breast cancer.
Françoise Debiais
Françoise Debiais
CONTINUING EDUCATION
STLAURENT
Under the aegis of SOFOM and AERIO
Presidents: Joseph Gligorov, Stéphane Culine, Matthieu Delaye & Christophe Tournigand - Chairpersons: Dil Sahali, Christophe Tournigand
Renal complications of immunotherapy.
Renal complications of immunotherapy.
Julie Belliere
Julie Belliere
Nephrological management in Cancer patients.
Nephrological management in Cancer patients.
Corinne Isnard Bagnis
Corinne Isnard Bagnis
Oncological management in renal transplant patients.
Oncological management in renal transplant patients.
Charlotte Fenioux
Charlotte Fenioux
Access of oncology interns to scientific publications.
Access of oncology interns to scientific publications.
Towards a certification program in medical oncology.
Towards a certification program in medical oncology.
Adrien Rousseau
Adrien Rousseau
CONSENSUS AND GUIDELINES FOR BREAST CANCER (1)
LASEINE
Under the aegis of St Paul and AROME
Presidents: Moïse Namer, Marc Spielmann, Yazid Belkacemi, Joseph Gligorov, Georges Chahine
Sentinel lymph nodes: when is it contraindicated?
Sentinel lymph nodes: when is it contraindicated?
Catherine Uzan
Catherine Uzan
Immediate reconstruction: to whom not to propose it ?
Immediate reconstruction: to whom not to propose it ?
Isabelle Sarfati, Anne Sabaila
Isabelle Sarfati, Anne Sabaila
Hypo fractionated schemes: to whom not to propose it ?
Hypo fractionated schemes: to whom not to propose it ?
Sofia Rivera
Sofia Rivera
Irradiation of the internal mammary chain: who should benefit from it?
Irradiation of the internal mammary chain: who should benefit from it?
Agnès Tallet
Agnès Tallet
What routine tests for the management of non-metastatic breast cancer.
What routine tests for the management of non-metastatic breast cancer.
Nina Radosevic
Nina Radosevic
What routine tests for the management of metastatic breast cancer.
What routine tests for the management of metastatic breast cancer.
Nina Radosevic
Nina Radosevic
Chemotherapy de-escalation in adjuvant setting: for whom?
Chemotherapy de-escalation in adjuvant setting: for whom?
Marc-Antoine Benderra
Marc-Antoine Benderra
Antihormonal treatment escalation in an adjuvant setting: how?
Antihormonal treatment escalation in an adjuvant setting: how?
Johanna Wassermann
Johanna Wassermann
CONSENSUS AND GUIDELINES FOR BREAST CANCER (2)
LASEINE
Under the aegis of St Paul and AROME
Presidents: Moïse Namer, Marc Spielmann, Yazid Belkacemi, Joseph Gligorov, Georges Chahine
Which strategy in metastatic situation for HER2 positive cancers?
Which strategy in metastatic situation for HER2 positive cancers?
Sandra Swain
Sandra Swain
HER2 low cancers: What to do?
HER2 low cancers: What to do?
Which optimal treatment in a non-metastatic in adjuvant and neoadjuvant situation?
Which optimal treatment in a non-metastatic in adjuvant and neoadjuvant situation?
Olivier Tredan
Olivier Tredan
BIOTECH IN ONCOLOGY
MISSISSIPI
Under the aegis of Gustave Roussy Transfert, Cancer Campus and Angels Santé
Chairperson(s): Jean-Pierre Armand (Gustave Roussy, Villejuif), Stéphane Loze (Angels Santé, Paris)
The acceleration induced by the « 2030 Innovation Plan »: the example of the Paris Saclay Cancer Cluster.
The acceleration induced by the « 2030 Innovation Plan »: the example of the Paris Saclay Cancer Cluster.
Éric Vivier, President of Paris Saclay Cancer Cluster association
Éric Vivier, President of Paris Saclay Cancer Cluster association
BIOTECH IN ONCOLOGY - PART II: «STARTUP PITCH»
MISSISSIPI
Under the aegis of Gustave Roussy Transfert, Cancer Campus and Angels Santé
Chairperson(s): Jean-Pierre Armand (Gustave Roussy, Villejuif), Stéphane Loze (Angels Santé, Paris)
HolisTM GV, an innovative patient-centered digital solution that aims to transform patient care for multimorbid elderly cancer patients. MYPL.
HolisTM GV, an innovative patient-centered digital solution that aims to transform patient care for multimorbi...
Christophe Vergne
Christophe Vergne
A new Biotech in onco-dermatology: from reflection to action! RIBONEXUS.
A new Biotech in onco-dermatology: from reflection to action! RIBONEXUS.
Caroline Robert
Caroline Robert
ScreenACT : Digital solutions to optimize recruitment in clinical trials. SCREENACT.
ScreenACT : Digital solutions to optimize recruitment in clinical trials. SCREENACT.
Sébastien Mourey
Sébastien Mourey
Fluorescent immunoconjugates to detect the invisible in real time, and reduce the severity of the surgery. VIEWAVES.
Fluorescent immunoconjugates to detect the invisible in real time, and reduce the severity of the surgery. VIE...
Frédéric Le Moigne
Frédéric Le Moigne
Ultra-sensitive ctDNA detection with NGS in liquid biopsies. FLOATING GENES.
Ultra-sensitive ctDNA detection with NGS in liquid biopsies. FLOATING GENES.
Gabriel Lerebours
Gabriel Lerebours
Polymer drug conjugate : unlocking the full potential of highly potent anticancer drugs. IMESCIA.
Polymer drug conjugate : unlocking the full potential of highly potent anticancer drugs. IMESCIA.
Tanguy Boissenot
Tanguy Boissenot
A Novel Bioreactor Design for Closed and Automated CAR T Cell Manufacturing. LIMULA.
A Novel Bioreactor Design for Closed and Automated CAR T Cell Manufacturing. LIMULA.
CONSENSUS AND GUIDELINES FOR ONCODERMATOLOGY
MISSISSIPI
President and Chairpersons: Barouyr Baroudjian, Céleste Lebbe, Caroline Robert, Donia Lassoued and Stéphane Barete
Adjuvant treatment for melanoma: which one and for who?
Adjuvant treatment for melanoma: which one and for who?
Emilie Routier
Emilie Routier
Discontinuation of Treatment in Responding Patients with metastatic melanoma.
Discontinuation of Treatment in Responding Patients with metastatic melanoma.
Ouidad Zehou
Ouidad Zehou
News in non-melanoma skin cancers in immunocompromised patients (organ transplant patients).
News in non-melanoma skin cancers in immunocompromised patients (organ transplant patients).
Stéphane Barete
Stéphane Barete
GYNECOLOGICAL CANCERS: "HIGHLIGHTS FROM THE SGO AND ASCO"
MISSISSIPI
Under the aegis of SFCO, GINECO GROUP and SFMPP
Chaipersons: Isabelle Ray Coquard, Pascal Pujol
Diagnostic and genomic news (or what's new on molecular markers?)
Diagnostic and genomic news (or what's new on molecular markers?)
Pascal Pujol, Laetitia Collet
Pascal Pujol, Laetitia Collet
Medical news (or what's new in surgery?)
Medical news (or what's new in surgery?)
Jérôme Alexandre
Jérôme Alexandre
Medical news (or what's new in surgery?)
Medical news (or what's new in surgery?)
Patricia Pautier
Patricia Pautier
Surgical news (or what's new in surgery?)
Surgical news (or what's new in surgery?)
Gwenaël Ferron, [oral] Enora Laas
Gwenaël Ferron, [oral] Enora Laas
CONSENSUS AND GUIDELINES FOR UROLOGY: PROSTATE CANCER CARE
STLAURENT
President and Chairpersons: Thierry Lebret, Arnaud Mejean, Mathieu Minsat, Luca Campedel and Ronan Flippot
-To which patient can we Offer active surveillance ?
-To which patient can we Offer active surveillance ?
Pierre Mongiat-Artus
Pierre Mongiat-Artus
- What support plan?
- What support plan?
Arnaud Mejean
Arnaud Mejean
- What are unnecessary toe choline applications?
- What are unnecessary toe choline applications?
Marc Bertaux
Marc Bertaux
- Place of chemotherapy.
- Place of chemotherapy.
Luca Campedel
Luca Campedel
- Place of iPARPs and Lu-PSMA.
- Place of iPARPs and Lu-PSMA.
Ronan Flippot
Ronan Flippot
INNOVATIONS IN RADIOTHERAPY
STLAURENT
Under the aegis of SFRO & SFJRO
Presidents: David Azria, Florence Huguet and Yasmine El Houat
Auto-segmentation, MRI dosimetry, real-time influencers: present or future?
Auto-segmentation, MRI dosimetry, real-time influencers: present or future?
Morgan Michalet
Morgan Michalet
Flash radiotherapy: electrons and protons: the first patient treated?
Flash radiotherapy: electrons and protons: the first patient treated?
Mahmut Ozsahin
Mahmut Ozsahin
Radiotherapy of refractory ventricular tachycardia: the French experience.
Radiotherapy of refractory ventricular tachycardia: the French experience.
Jonathan Khalifa
Jonathan Khalifa
Breast radiotherapy in 5 fractions: for whom?
Breast radiotherapy in 5 fractions: for whom?
Sofia Rivera
Sofia Rivera
Radiotherapy of the primary tumor in a metastatic situation: standard in all indications?
Radiotherapy of the primary tumor in a metastatic situation: standard in all indications?
Youssef Ghannam
Youssef Ghannam
HIGHLIGHTS FITI* SESSION (International Meetings Update)
LASEINE
2022 A MAJOR ONCOLOGY YEAR
Presidents and Chairpersons: Charles Canova, Aurélien Gobert, Sandra Swain, Romain Cohen
Update of ASCO 2022, SABCS 2021 and ESMO Breast 2022 for Breast Cancer highlights.
Update of ASCO 2022, SABCS 2021 and ESMO Breast 2022 for Breast Cancer highlights.
Sandra Swain
Sandra Swain
RH+ HER2- in a metastatic situation: recommendations in 2022.
RH+ HER2- in a metastatic situation: recommendations in 2022.
Jean-Yves Pierga
Jean-Yves Pierga
Best of 2022: thoracic oncology and Radiation therapy.
Best of 2022: thoracic oncology and Radiation therapy.
Charles Canova
Charles Canova
Best of 2022 in Urology.
Best of 2022 in Urology.
Aurélien Gobert
Aurélien Gobert
Focus on MSI tumors.
Focus on MSI tumors.
Thierry André
Thierry André
Higlights in GI oncology.
Higlights in GI oncology.
Romain Cohen
Romain Cohen
CONSENSUS AND GUIDELINES FOR GI TUMORS
MISSISSIPI
Under the aegis of Prodige Group, UNICANCER GI, GERCOR, FFCD
Chairpersons: Thomas Aparicio & Christelle de la Fouchardière
Advantage of determining circulating tumor DNA.
Advantage of determining circulating tumor DNA.
Frédéric Di Fiore
Frédéric Di Fiore
Which targeted therapies in the treatment of cholangiocarcinomas?
Which targeted therapies in the treatment of cholangiocarcinomas?
Management of primary and secondary tumors of the peritoneum.
Management of primary and secondary tumors of the peritoneum.
Diagnosis and treatment of HER2 digestive tumors?
Diagnosis and treatment of HER2 digestive tumors?
Romain Cohen
Romain Cohen
How to treat locally advanced pancreatic adenocarcinoma?
How to treat locally advanced pancreatic adenocarcinoma?
Pascal Hammel
Pascal Hammel
CANCER, APRÈS-CANCER, RESSOURCES ET RÉSILIENCE
STLAURENT
Sous l'égide d'Europa Donna, Life is Rose, L'UDP, Patients en réseau
President and Chairperson: Jean-Jacques Zambrowski
Le Café du Rétablissement : un exemple d'offre dans le Parcours de soins en oncologie.
Le Café du Rétablissement : un exemple d'offre dans le Parcours de soins en oncologie.
Catherine Tourette-Turgis et Christine L Pichard
Catherine Tourette-Turgis et Christine L Pichard
Rôle thérapeutique de l'Acupuncture en cancérologie.
Rôle thérapeutique de l'Acupuncture en cancérologie.
Philippe Jeannin
Philippe Jeannin
Ressources et résilience dans la vraie vie.
Ressources et résilience dans la vraie vie.
Nathalie Savariaud
Nathalie Savariaud
Ressources et résilience du point de vue psychique.
Ressources et résilience du point de vue psychique.
Maryline Baranes
Maryline Baranes
Europadonna
Europadonna
Brigitte Heuls
Brigitte Heuls
CONSENSUS AND GUIDELINES FOR SARCOMA
STLAURENT
Under the aegis of GSF - GETO & NET- SARC
Chairperson(s): Axel Le Cesne, Mehdi Brahmi and Aurore Vozy
Reference center and sarcoma.
Reference center and sarcoma.
François Gouin
François Gouin
Cellular therapy for sarcoma treatment.
Cellular therapy for sarcoma treatment.
Mehdi Brahmi
Mehdi Brahmi
Molecular medicine of cancer: ongoing actions and challenges. Is more better ? Profiler 2: a randomized trial testing 2 different panel sizes.
Molecular medicine of cancer: ongoing actions and challenges. Is more better ? Profiler 2: a randomized trial ...
Mehdi Brahmi
Mehdi Brahmi
The Multisarc protocol.
The Multisarc protocol.
Antoine Italiano
Antoine Italiano
New agents in routine or close to routine use.
New agents in routine or close to routine use.
Christophe Massard
Christophe Massard
HEART VESSELS AND CANCERS
STLAURENT
Chairperson(s): Joe-Elie Salem, Francis Cajfinger and Corinne Frere
Cancer and cardiac metastasis: how to make the diagnosis?
Cancer and cardiac metastasis: how to make the diagnosis?
Stéphane Ederhy
Stéphane Ederhy
Direct oral anticoagulant for the treatment of cancer-associated thrombosis: an update.
Direct oral anticoagulant for the treatment of cancer-associated thrombosis: an update.
Corinne Frère
Corinne Frère
What are the prerequisites to know or avoid before setting up an anticoagulant treatment in patients with cancer and thrombosis?
What are the prerequisites to know or avoid before setting up an anticoagulant treatment in patients with canc...
Audrey Bellesoeur
Audrey Bellesoeur
